Mobile phone support for adults managing type 2 diabetes
Tests a phone-based support program adapted to adults with type 2 diabetes.
Key facts
- Who runs it
- Vanderbilt University Medical Center
- Where
- Birmingham and Nashville, United StatesSee the 2 sites
- Trial code
- Registry title
- MObile Support Adapted to Individual Contexts
- Status
- Enrolling by invitation
- People taking part
- 547 people, planned
- Started
- 21 Mar 2025
- Expected to end
- 30 Nov 2028
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- MOSAIC
- Print Materials
- Record updated
- 5 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-75 with type 2 diabetes who take diabetes medicine and get care at a partner clinic. A support person may also join.
- Age
- 18-75 years for people with diabetes; support persons must be 18 years or older.
- Sex
- All sexes can join.
- Disease stage
- Type 2 diabetes, treated as an outpatient and living in the community (not in a nursing facility).
- Earlier treatment
- Must be prescribed at least one diabetes medication and take medication on their own.
Main reasons for not taking part
- Currently pregnant
- Currently in treatment for cancer
- End-stage renal disease, congestive heart failure, dementia or schizophrenia
- Receiving hospice services
- Cannot communicate by phone or receive and respond to a text
The registry criteria, word for word
Show all 24 criteriaShow less
Who can take part
- PERSONS WITH DIABETES:
- Speaks and reads in English
- 18-75 years old
- Diagnosed with type 2 diabetes
- Receiving outpatient care from a partnering clinic
- Community-dwelling (e.g., not in a nursing facility)
- Prescribed at least one diabetes medication
- Owns a mobile phone; SUPPORT PERSONS:
- Speaks and reads in English
- 18 years or older
- Owns a mobile phone
Who cannot take part
- Receiving hospice services*
- Does not take medication on his/her own/medication administered by someone else; SUPPORT PERSONS:
- PERSONS WITH DIABETES:
- Currently undergoing treatment for cancer (e.g., radiation, chemotherapy)
- Diagnosed with end-stage renal disease
- Diagnosed with congestive heart failure
- Diagnosed with dementia
- Unable to communicate by phone
- Currently pregnant
- Diagnosed with schizophrenia
- Demonstrated an inability to receive and respond to a text
- Demonstrated inability to receive \& respond to a text
- Unable to communicate by phone
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- University of Alabama at BirminghamBirmingham, United StatesEnrolling by invitation
- Vanderbilt University Medical CenterNashville, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This behavioral clinical trial evaluates an adaptively tailored, mobile phone-delivered intervention (MOSAIC) designed to support adults managing their type 2 diabetes. Adaptive means the intervention can change over time. Tailored means the intervention may be different for different participants. The main questions the study will aim to answer are:
Read full original descriptionShow less
1. Does the diabetes education and support delivered via the MOSAIC adaptive mobile phone-delivered intervention improve outcomes more than diabetes education and support delivered via print materials alone? This aim compares the study arms on outcomes such as glycemic management (hemoglobin A1c), diabetes distress, and psychosocial well-being. This aim also compares the study arms on intervention targets (mediators) including diabetes self-efficacy and self-care behaviors. 2. For whom does the MOSAIC adaptive tailoring approach improve outcomes more than the print materials alone? This aim examines how well the tailoring rules used for the MOSAIC intervention worked for different participants on the outcomes examined in the first aim.
Participants will enroll in a 16-month study with assessments every 4 months. Assessments include completion of an A1c test and a survey. For those assigned to MOSAIC, they will experience 12-months of mobile phone-delivered support with 3 opportunities for intervention tailoring.
The 2 groups in the trial
- MOSAICTreatment being tested
PWD participants will receive MOSAIC components (monthly phone coaching and text message support for goals and medication adherence) for 12 months. PWD participants will receive high-quality print materials upon enrollment and quarterly newsletters on healthy living with diabetes. All SP participants invited by PWD participants assigned to MOSAIC will receive high-quality print materials upon enrollment and quarterly newsletters on healthy living with diabetes. SPs may participate in monthly phone coaching and/or receive text message support tailored to the goal set by the linked PWD.
Treatment: MOSAIC and Print Materials
- Print MaterialsPlacebo, for comparison
PWD participants will receive text messages advising how to access their study A1c test results, and receive high-quality print materials including a book upon enrollment and quarterly newsletters on health living with diabetes.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- MObile Support Adapted to Individual Contexts (MOSAIC Study)
- Plain-language title
- Mobile phone support for adults managing type 2 diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06828549, who can take part
- Record updated
- 5 March 2026